SCIOMICS

At Sciomics, we believe that our explorative proteomic and post-translational modification profiling platform enables true progress in precision medicine. Therefore, our internal development pipeline of innovative biomarker signatures for precision medicine is based on this powerful platform... In addition, we offer services based on our scioDiscover profiling platform and R&D collaborations for the discovery and validation of novel biomarkers, for drug target screening, the characterization of disease models, and for the analysis of pathway activity as well as mode-of-action analyses. What sets us apart is our team of scientific experts that takes pride in custom-tailoring every project and consulting clients throughout the project. Our full service ranges from discussing experimental designs to in-depth data analysis and a comprehensive study report. Fast and cost-efficient, Sciomics‘ powerful high-content, high-throughput antibody array platform delivers reliable results that can..

Also known as: Sciomics GmbH

Registration numbers: HRB716969 (W)

VAT numbers: DE289272460